Xie Fuli, Liang Lili, Wang Yuzhou
Department of Neurology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China.
BMC Neurol. 2025 Mar 12;25(1):102. doi: 10.1186/s12883-025-04062-2.
Carotid free-floating thrombi (CFFT) are uncommon but pose a high risk of embolic stroke. While vascular intervention is often favored, this case study demonstrates the potential of short-term anticoagulation, guided by thorough imaging, as an alternative treatment strategy.
We present a patient with an acute ischemic stroke (NIHSS 15) due to middle cerebral artery (MCA) occlusion. Intravenous alteplase successfully revascularized the MCA. However, subsequent imaging revealed a CFFT as the likely source of the occlusion. Rather than immediate surgical intervention, we opted for a treatment strategy guided by comprehensive radiological assessments, including high-resolution MRI and serial ultrasounds. These assessments suggested the thrombus was newly formed. Based on this, we hypothesized it would be responsive to anticoagulation. Indeed, short-term enoxaparin therapy resulted in significant resolution of the CFFT.
This case highlights the efficacy of anticoagulation for treating newly formed CFFT, suggesting a potential alternative to immediate intervention when guided by detailed radiological evaluation. This case introduces a novel approach that may expand treatment options for this challenging condition.
颈动脉游离血栓(CFFT)并不常见,但会引发较高的栓塞性中风风险。虽然血管介入治疗通常是首选,但本病例研究表明,在全面成像的指导下,短期抗凝作为一种替代治疗策略具有潜力。
我们报告一名因大脑中动脉(MCA)闭塞导致急性缺血性中风(美国国立卫生研究院卒中量表评分15分)的患者。静脉注射阿替普酶成功使MCA再通。然而,随后的影像学检查显示CFFT可能是闭塞的来源。我们没有立即进行手术干预,而是选择了一种由包括高分辨率MRI和系列超声在内的全面放射学评估指导的治疗策略。这些评估表明血栓是新形成的。基于此,我们推测它对抗凝治疗会有反应。事实上,短期使用依诺肝素治疗使CFFT明显消退。
本病例突出了抗凝治疗新形成的CFFT的疗效,表明在详细的放射学评估指导下,这是一种可替代立即干预的潜在方法。本病例引入了一种新方法,可能会扩大针对这种具有挑战性病症的治疗选择。